Skip to playerSkip to main content
  • 5 months ago
उत्तराखंड में अमेरिका एफडीए अप्रूव्ड 6 फार्मा कंपनियां हैं. जिसके जरिये 1500 से 2000 करोड़ रुपए तक की दवाएं एक्सपोर्ट होती हैं.

Category

🗞
News
Transcript
00:00foreign
00:04foreign
00:14foreign
00:28approved 6 pharma company
00:29which is due to 1500-2000 crore
00:33which is exported to America
00:35if this sector
00:37would be a tariff
00:38what will happen to this?
00:40Let us know
00:41that Trump has 50% tariff
00:44in India
00:47that he is punishing
00:50we have a punishment
00:52in industries
00:53where the labor
00:57will be a lot
00:58so there will be a lot of production
01:02so the labor intensive
01:04will be more effective
01:07for the 26 years
01:08we are saying that if this tariff is going to be 26
01:12then no doubt
01:13will be 1.2% of the growth rate
01:17this is also a trade war
01:19so there are some losses
01:21and some benefits
01:23so both of us are doing
01:25in India
01:26that the industry association of Uttarakhand
01:28also had this
01:30with respect to this
01:32that they have said
01:33that they have said
01:34that we are investigating
01:35so it is the process is on
01:39the investigations are on
01:40but the end result
01:42is what we are seeing
01:43that we are seeing
01:44that we are seeing
01:45that the end result
01:46is what we are seeing
01:47that is
01:48because if the tariff
01:50is supposed to be 25%
01:51in the pharma products
01:52then the price of the drug
01:53is going to be
01:54up to the price
01:55in the US
01:56that the price of the drug
01:57is going to be
01:58up to the price
01:59in the US
02:00so this is what we are seeing
02:01and understanding
02:02and the price of the drug
02:03is going to be
02:04so this is what we are seeing
02:05now we are seeing
02:06wait and watch
02:07that we are seeing
02:08in total
02:0940%
02:10pharmaceutical products
02:11are
02:12in the US
02:1340%
02:14share
02:15market share
02:17Indian drugs
02:18system
02:19US
02:20share
02:21and
02:22this is a substantial
02:24value
02:25that
02:26is
02:27about
02:2820 billion
02:29dollars
02:30on the
02:31price of
02:32drug
02:33pharmaceutical
02:34products
02:35supply
02:3630 companies
02:37are
02:39approved
02:40and
02:41there are 6 companies
02:42who exist
02:43in Utrakhand
02:44which have
02:45approved
02:46and
02:47if we look at
02:49India's total
02:51pharma
02:52production
02:53is
02:5420%
02:55production
02:56is
02:57Utrakhand
02:58and
02:592,000-2,000
03:00crore
03:01export
03:02to
03:03these companies
03:04do
03:05in
03:06Utrakhand
03:07Drugs
03:08Manufacturers
03:09Association
03:10Sanjay
03:11Sikaria
03:12Trump
03:13tariff
03:14not
03:15different
03:16from
03:17United States
03:18and
03:19the
03:20most
03:21of
03:22the
03:23manufacturing
03:24units
03:25are
03:26in India
03:27approved
03:28and
03:29FDA
03:30approved
03:31and
03:32the
03:33regulatory
03:34body
03:35is
03:36FDA
03:37and
03:38FDA
03:39are
03:40approved
03:41in India
03:42and
03:43they
03:44have
03:4550%
03:47tax
03:48which
03:49has
03:50increased
03:51on their
03:52tariff
03:53and
03:54impact
03:55on their
03:56taxes
03:57because
03:58if
03:59the
04:00taxes
04:01are
04:02expensive
04:03and
04:04Trump
04:05has
04:06said
04:07that
04:08the
04:09rate
04:10of
04:11American
04:12companies
04:13have
04:14also
04:15paid
04:1615
04:17times
04:18to
04:19charge
04:20them
04:21to
04:22that
04:23level
04:24and
04:25if
04:26the
04:27tax
04:28from
04:29India
04:30will
04:31fall
04:32through
04:33Trump
04:34is
04:35unpredictable
04:36personality
04:37that
04:38can
04:39do
04:40and
04:41we
04:42think
04:43that
04:44if
04:45they
04:46do
04:47it
04:48will
04:49be
04:50as
04:51as
04:52as
04:53as
04:54as
04:55as
04:56as
04:57as
04:58as
04:59as
05:00as
05:01that
05:02us
05:03is
05:06as
05:07as
05:08as
05:09as
05:10as
05:11as
05:13as
05:14as
05:17as
05:18as
05:19as
05:20as
05:21as
05:22the medicine will continue to go there.
05:25One point.
05:26The second point is that the industry is to put it there.
05:31The main target is to put it there.
05:35Look, there are big companies who can easily put their plants there.
05:41There are many labor costs.
05:45But then, the cost of the market will be able to compete on the industry.
05:54How much success is there?
05:56We can see it in the time.
05:58We can see it in the foreign policy.
06:04The pharmaceutical sector is out of Trump's tariffs.
06:07If this sector has come,
06:09the country will be a big deal.
06:13It is necessary that,
06:15the rest of the market will be a big deal.
06:18It will be easy to tackle the tariffs.
06:23The report is ETV.
06:24The report is ETV.
Be the first to comment
Add your comment

Recommended